HomeSCNI • NASDAQ
add
Scinai Immunotherapeutics Ltd - ADR
$1.56
Makalipas ang Oras ng Trabaho:(1.92%)+0.030
$1.59
Sarado: Set 12, 6:40:11 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$1.58
Sakop ng araw
$1.53 - $1.62
Sakop ng taon
$1.40 - $6.18
Market cap
2.36M USD
Average na Volume
269.76K
P/E ratio
0.20
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 386.50K | 36.09% |
Gastos sa pagpapatakbo | 1.25M | -33.09% |
Net na kita | -2.07M | 10.98% |
Net profit margin | -534.80 | 34.59% |
Kita sa bawat share | — | — |
EBITDA | -1.53M | 0.10% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 989.00K | -67.85% |
Kabuuang asset | 11.84M | -20.27% |
Kabuuang sagutin | 3.98M | -82.01% |
Kabuuang equity | 7.86M | — |
Natitirang share | 1.51M | — |
Presyo para makapag-book | 1.07 | — |
Return on assets | -39.73% | — |
Return on capital | -46.05% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.07M | 10.98% |
Cash mula sa mga operasyon | -1.29M | 26.76% |
Cash mula sa pag-invest | -6.00K | 0.00% |
Cash mula sa financing | 790.50K | 6,487.50% |
Net change in cash | -482.00K | 74.27% |
Malayang cash flow | -945.88K | 21.32% |
Tungkol
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
Itinatag
Ene 1, 2003
Website
Mga Empleyado
31
